DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 210 filers reported holding DIPLOMAT PHARMACY INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $150,000 | -44.0% | 11,174 | -18.5% | 0.01% | -33.3% |
| Q3 2018 | $268,000 | -22.8% | 13,717 | +1.2% | 0.01% | -30.8% |
| Q2 2018 | $347,000 | +27.1% | 13,560 | -1.0% | 0.01% | +18.2% |
| Q1 2018 | $273,000 | +1.5% | 13,701 | +2.0% | 0.01% | 0.0% |
| Q4 2017 | $269,000 | +7.6% | 13,430 | +11.5% | 0.01% | 0.0% |
| Q3 2017 | $250,000 | +36.6% | 12,050 | -2.4% | 0.01% | +37.5% |
| Q2 2017 | $183,000 | – | 12,348 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |